Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1701982

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1701982

Aerosol Delivery Devices Market Report by Product, Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Non-Respiratory Diseases), Distribution Channel, and Region 2025-2033

PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global aerosol delivery devices market size reached USD 49.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 75.2 Billion by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The market is primarily driven by the rising rates of respiratory illnesses, improvements in inhalation technology, growing geriatric population, rising healthcare costs, and a growing global awareness regarding the availability of customized medicine.

Aerosol delivery devices are used in drug delivery and treating respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis, pulmonary arterial hypertension, infectious pulmonary. They lower dosage requirements, reduce systemic adverse effects and improve the ability of patients to self-administer medication. Some of the commonly available aerosol delivery devices are pressurized metered-dose inhalers, nebulizers, and valved holder chambers. At present, smart aerosol drug delivery devices are used in non-respiratory conditions, such as diabetes, analgesia, thyroid disorders, and genetic diseases, due to the advent of novel macromolecular medications.

Aerosol Delivery Devices Market Trends:

The global outbreak of the coronavirus disease (COVID-19) that leads to acute respiratory infections among patients represents one of the key factors driving the need for aerosol delivery devices. These devices assist in treating obstructive airway diseases at home and in healthcare settings. Apart from this, the rising prevalence of chronic respiratory infections due to surging air pollution levels, allergens and occupational risks, and the increasing number of individuals who smoke tobacco and drink is propelling the market growth. Moreover, a considerable rise in the geriatric population, which is more vulnerable to developing serious health illnesses, is positively influencing the demand for portable inhalation devices that are convenient and economical. Besides this, market players are developing novel aerosol delivery devices that help treat chronic inflammation and infection in the lungs and improve airway clearance in patients with cystic fibrosis (CF). Furthermore, they are offering mini ultrasonic nebulizers and inhalers through e-commerce channels that have automatic memory and are easy to use while traveling. This, in confluence with the escalating demand for personalized drug therapy and the increasing use of online channels for purchasing medical supplies, is driving the market.

Key Market Segmentation:

Breakup by Product:

  • Dry Powder Inhalers
  • Single Dose Inhalers
  • Multi Dose Inhalers
  • Metered Dose Inhalers
  • Conventional Pressurized Inhalers
  • Soft Mist Inhalers
  • Nebulizers
  • Jet Nebulizers
  • Ultrasonic Wave Nebulizers
  • Vibrating Mesh Nebulizers

Breakup by Application:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Non-Respiratory Diseases
  • Diabetes
  • Analgesia
  • Parkinson's Disease

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Stores

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report

  • 1.What was the size of the global aerosol delivery devices market in 2024?
  • 2.What is the expected growth rate of the global aerosol delivery devices market during 2025-2033?
  • 3.What are the key factors driving the global aerosol delivery devices market?
  • 4.What has been the impact of COVID-19 on the global aerosol delivery devices market?
  • 5.What is the breakup of the global aerosol delivery devices market based on the product?
  • 6.What is the breakup of the global aerosol delivery devices market based on the distribution channel?
  • 7.What are the key regions in the global aerosol delivery devices market?
  • 8.Who are the key players/companies in the global aerosol delivery devices market?
Product Code: SR112025A4892

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Aerosol Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Dry Powder Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Single Dose Inhalers
      • 6.1.2.2 Multi Dose Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Metered Dose Inhalers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Conventional Pressurized Inhalers
      • 6.2.2.2 Soft Mist Inhalers
    • 6.2.3 Market Forecast
  • 6.3 Nebulizers
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Jet Nebulizers
      • 6.3.2.2 Ultrasonic Wave Nebulizers
      • 6.3.2.3 Vibrating Mesh Nebulizers
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cystic Fibrosis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Non-Respiratory Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Key Segments
      • 7.4.2.1 Diabetes
      • 7.4.2.2 Analgesia
      • 7.4.2.3 Parkinson's Disease
    • 7.4.3 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aerogen
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 GlaxoSmithKline plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Koninklijke Philips N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Metall Zug AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Recipharm AB (publ)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vectura Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
Product Code: SR112025A4892

List of Figures

  • Figure 1: Global: Aerosol Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Aerosol Delivery Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Aerosol Delivery Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Aerosol Delivery Devices Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Aerosol Delivery Devices Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Aerosol Delivery Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Aerosol Delivery Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Aerosol Delivery Devices (Nebulizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Aerosol Delivery Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Aerosol Delivery Devices (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Aerosol Delivery Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Aerosol Delivery Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Aerosol Delivery Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Aerosol Delivery Devices (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Aerosol Delivery Devices (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Aerosol Delivery Devices Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Aerosol Delivery Devices Industry: SWOT Analysis
  • Figure 78: Global: Aerosol Delivery Devices Industry: Value Chain Analysis
  • Figure 79: Global: Aerosol Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Aerosol Delivery Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Aerosol Delivery Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Aerosol Delivery Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Aerosol Delivery Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Aerosol Delivery Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Aerosol Delivery Devices Market: Competitive Structure
  • Table 7: Global: Aerosol Delivery Devices Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!